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Objective: To derive and validate a prediction rule in patients with acute chest pain (CP) without
existing known coronary disease.
Methods: Cohort study including 2233 patients with CP. Based on clinical judgment, 1435 were
discharged as very low risk and the remaining 798 underwent exercise tolerance test (ETT). End point:
6-month composite of cardiovascular death, nonfatal myocardial infarction, and revascularization. The
prediction rule was derived from a randomly selected test cohort (n = 1106) summing factors of
variables selected by multivariate regression analysis: CP score higher than 6 (factor of 3), male gender,
age older than 50 years, metabolic syndrome, and diabetes mellitus (factor of 1, for each). The
prediction rule was validated in the remaining cohort (n = 1127). All patients with CP were categorized
into 3 groups: group A (prediction rule 0-1), B (2-4), or C (5-6). Outcomes and prognostic yield of ETT
were compared among each group.
Results: In the test cohort, 55 patients (5%) reached the composite end point. Event rate increased as the
prediction rule increased: 1% for group A, 6% for B, and 25% for C (P b .001). This pattern was
confirmed in the validation cohort (P b .001). A normal ETT did not significantly improve the high
(99%) negative predictive value in group A and did not succeed in excluding the composite end point
(17%) in group C.
Conclusions: In patients with acute CP without existing coronary disease, a prediction rule based on
clinical characteristics provided a useful method for prognostication with possible implication in
decision making.
© 2010 Elsevier Inc. All rights reserved.⁎ Corresponding author. Tel.: +39 33 8747 2294, fax: +39 05 5794 7454.
E-mail address: aaaconti@hotmail.com (A. Conti).
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Patients with chest pain (CP) and nondiagnostic initial
work-up, including electrocardiogram (ECGs) and serial
troponins, and without existing known coronary artery
Table 1 Chest pain score
Location
Substernal, precordial +3
Left chest, neck, lower jaw, epigastrium +1
Radiation
Either arm, shoulder, back, neck, lower jaw +1
Character
Crushing, pressing, heaviness +3
Sticking, pleuritic, pinprick +1
Associated symptoms
Dyspnea, nausea, diaphoresis +2
Previous history of CP +3
136 A. Conti et al.disease are currently considered at low risk of short-term
coronary events (b2% of death and/or myocardial infarc-
tion) [1,2]. However, in that large and heterogeneous
population with a mean low prevalence of coronary disease,
diagnosis of acute coronary syndrome still represents a
challenge. In low-risk patients, a stress test aids the
evaluation of suspected coronary disease and it is usually
performed in the Emergency Department (ED), in the CP
unit, or on an outpatient basis shortly after discharge;
however, submitting patients to this diagnostic strategy is
usually based on unstandardized clinical judgment [2-4]. In
patients with defined acute coronary syndrome, several
prediction rules are available for risk stratification [5-7];
conversely, no study has validated the usefulness of a
prediction rule including coronary risk factors [8-11] in a
large cohort of patients with low-risk CP. Moreover, some
of the major risk factors for atherosclerosis (eg, hyperten-
sion, hypercholesterolemia, obesity, cigarette smoking,
family history) have been found to be weakly predictive
of the likelihood of coronary events in this population
[12,13]. Recently, a cluster of coronary risk factors defined
as metabolic syndrome (MS) have received attention in
global cardiovascular risk assessment, similar to the
awareness diabetes mellitus (DM) has received [14-16].
To our knowledge, the usefulness of including MS in the
diagnostic work-up of patients with acute CP has not been
evaluated. Indeed, no standardized prediction rule is yet
available for stratification of patients with low-risk CP in
the ED [2,17]. Thus, the primary goal of this study was to
derive and validate in an ED a clinical prediction rule for
prognostication in patients with low-risk CP.2. Methods
2.1. Patient selection
Consecutive adult patients with CP who presented to our
ED (tertiary care teaching hospital), during the years 2002 to
2005, with normal ECG and normal troponin levels were
admitted to the CP unit and considered for the study [2].
Patients with existing known coronary artery disease or with
a life expectancy less than 6 months were excluded from the
study. All patients gave their written consent for study
participation. The study was approved by the local institu-
tional review board.
2.2. Management of patients and study protocol
In the CP unit, all patients underwent a first-line, 6-hour
work-up with characterization of CP by a previously
validated CP score (Table 1) [18], serial 12-lead ECGs
[2,19], and serial troponins. Moreover, the presence of DM,
MS, arterial hypertension, familial history of coronary
disease (≤65 years old), and current smoking was evaluated.Diagnosis of MS consisted of history or presence of 3 or
more of the following: high fasting glucose (N110 mg/dL),
high blood pressure (systolic blood pressure N130 mm Hg
and diastolic blood 80 pressure N85 mm Hg), low high-
density lipoprotein cholesterol (b40 mg/dL in men and
b50 mg/dL in women), high triglycerides (N150 mg/dL), and
central obesity (waist circumference N102 mm in men and 88
mm in 82 women) [14,15]. Diagnosis of DM consisted of
history or presence of fasting glucose greater than 125 mg/dL
in at least 2 measurements. Patients with DM were excluded
from the MS group. Baseline clinical characteristics of
patients of the study were derived from anamnestic data
obtained from patients, parents, caregivers, or events
analyzed by review of previous hospital or laboratory data
that are available on the hospital network. When we were not
able to obtain any information regarding some of the
considered risk factors, we concluded that the patient did
not have that risk factor, avoiding overestimation of coronary
risk profile. Resting echocardiography was performed in all
patients [2,17].
During the management in the CP unit, patients who
were found as having ischemic ECG changes [18], and/or
abnormal troponin I levels, and/or wall motion abnormal-
ities at echocardiography were considered at high risk of
coronary events; thus they were referred for urgent
coronary angiography [19,20]. Patients with normal serial
ECG and troponins, normal echocardiography, and a CP
score lower than 4 were considered at very low risk of
coronary disease [2,17] and they were discharged and
followed up at 6 months. The remaining patients with CP
score higher than 4 and without existing known coronary
disease were considered low-risk patients and underwent
early in-hospital maximal exercise tolerance test (ETT)
[4,18]. Patients with a positive test were considered at high
risk of coronary events; they were admitted and referred for
early coronary angiography [19-21]. Conversely, patients
with normal ETT were considered at very low risk; they
were discharged home and followed up at 6 months
[17,22]. Follow-up data were gathered by means of
monthly telephonic interviews up to the sixth month, and
all events were analyzed by review of hospital and
laboratory data.
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The primary outcome was a composite of cardiovascular
death, nonfatal myocardial infarction, or new or recurrent
severe cardiac ischemia requiring urgent revascularization.
Acute myocardial infarction was defined according to
international guidelines [23].
2.4. Statistical analysis
A multivariate model for prognostication of risk for
experiencing at least 1 element of the composite end point
was developed. The model incorporated baseline character-
istics previously reported to be important [24-28]. The model
derivation was restricted to the test cohort of patients selected
by retrospective random sampling of about 50% of the
overall population (n = 1106). A total of 7 baseline
characteristics arranged in a dichotomous fashion were
screened as candidate predictors (Table 2). After each
variable was tested in a univariate regression model, those
that achieved a significance level of P b .20 were selected for
testing in a multivariate stepwise (backward elimination)
logistic regression model. Variables associated with P b .05
were retained in the final model. By the developed multi-
variate model 5 variables were included. A factor directly
proportional to the odds ratio of that variable was assigned: a
factor of 3 for CP score higher than 6; a factor of 1 for each of
male sex, age older than 50 years, MS, and DM. The rule was
then calculated by arithmetic sum and was validated in the
validation cohort. We tested for homogeneity the prediction
rule in the validation cohort by comparing the slope of the
increase of event rate with the increase in the score of the
Florence prediction rule using least squares linear regression
analysis. To asses the model's discrimination power toTable 2 Baseline characteristics of patients with CP and nondiagnos
Total (N = 2233) Test cohor
Age (y) 50.5 ± 14.9 50.31 ± 14
Gender (male) 1358 (59.9%) 670 (60.6%
Diabetes 131 (5.9%) 58 (5.2%)
Metabolic syndrome 114 (5.1%) 57 (5.2%)
Hypertension 380 (17%) 187 (16.9%
Hyperlipemia 303 (13.6%) 159 (14.4%
Central obesity 65 (2.9%) 31 (2.8%)
Fasting glucose 131 (8.6%) 89 (8%)
Smokers 246 (11%) 116 (10.5%
Familiarity for CAD 88 (3.9%) 43 (3.9%)
Chest pain score 3.3 ± 2.6 3.3 ± 2.6
Primary outcome 108 (4.8%) 55 (5%)
Urgent revascularization 81 (3.6%) 44 (4%)
Myocardial infarction 32 (1.4%) 14 (1.3%)
Death 0 0
CAD indicates coronary artery disease.predict the composite end point, we compared the area under
the receiver operating characteristic curve between the
validation and the test cohort [29,30]. Fisher exact test was
used when expected frequencies are less than 5. P values are
2 sided, and a P value of less than .05 was considered to
indicate statistical significance. Calculations were performed
with the SPSS statistical package (version 14, SPSS, Inc,
Chicago, Ill).3. Results
During the years 2002 to 2005, 6396 patients with CP
were evaluated (Fig. 1). Of these, 3751 were considered at
high risk of short-term coronary events and were excluded
from the study [19,20]. The remaining 2645 patients, with
normal ECG, were admitted to our CP unit [2,17]. During
the first-line work-up, 389 patients developed ischemic
ECG changes, and/or abnormal troponins, and/or wall
motion abnormalities at echocardiography; all these
patients were considered at high risk of coronary events
and were referred for urgent coronary angiography
[19,20]. The work-up was normal in 2256 patients;
23 patients declined to participate in the study; therefore
2233 patients were included in the study. Of these, 1435
were considered at very low risk and were discharged
from the CP unit, whereas 798 were considered at low risk
and underwent in-hospital ETT. Those with positive ETT
(n = 142, 17.8%) were admitted, whereas those with
normal ETT (n = 656, 82.2%) were discharged as very
low risk patients (Fig. 1).
The clinical characteristics of patients enrolled are
shown in Table 2. At 6-month follow-up, no patient was
lost to follow-up and no patient died; 108 patients (4.8%)tic initial work-up
t (n = 1106) Validation cohort (n = 1127) P
.8 50.8 ± 15 .467
) 688 (61%) .828
73 (6.5) .242
57 (5.1%) .924
) 193 (17.1%) .910
) 144 (12.8%) .293
34 (3.0%) .802
102 (9.1%) .406
) 130 (11.5%) .457
45 (4.0%) .914
3.3 ± 2.6 .844
53 (4.7%) .768
37 (3.3%) .429
18 (1.3%) .594
0 1.000
Fig. 1 Flow diagram of participants in the study.
138 A. Conti et al.reached the composite end point of myocardial infarction
or revascularization.
3.1. Derivation of the Florence prediction rule
The test cohort for development of the Florence
prediction rule consisted of a randomized sample of
1106 patients; in this cohort, 5.0% reached the end point
(Table 2). Of 7 original candidate variables, only 5 proved toTable 3 Association between clinical variables and composite end p
coronary revascularization) at univariate and multivariate logistic regre
Variables Univariate analysis
OR 95% CI
Chest pain score N6 11.21 6.33-19.84
Metabolic syndrome 6.23 3.08-12.64
Age N50 y 5.11 2.55-10.25
Diabetes mellitus 3.41 1.53-7.60
Gender (male) 1.78 0.97-3.27
Familiarity for CAD 2.03 0.70-5.91
Smoke 1.26 0.55-2.86
OR indicates odds ratio.be significant in the multivariate analysis and formed the
final group of predictor variables (Table 3). As the parameter
estimate of CP score higher than 6 had a magnitude about 3-
fold higher than the others, the risk score was calculated
giving a value of 3 to CP score higher than 6 and a value of 1
to all the other variables when present (Table 3). Thus,
patients in the test cohort were categorized by the sum of
assigned values, obtaining 7 categories as shown in Fig. 2.
There is a progressive, significant pattern of increasing eventoint (death and/or acute myocardial infarction and/or urgent
ssion analysis
Multivariate analysis
P OR 95% CI P
b.001 7.03 3.80-12.99 b.001
b.001 3.03 1.36-6.79 .007
b.001 2.87 1.38-6.07 .005
.003 2.56 1.07-6.16 .035
.062 2.31 1.20-4.45 .012
.192 – – –
.579 – – –
Fig. 2 Clinical variables considered in patients enrolled in the
study and correlation with the rate of the composite end point.
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cohort (149, P b .001). The C statistic for the model in the
test cohort was 0.83 (95% CI, 0.77-0.88; P = .029).
3.2. Validation of the Florence prediction rule
The validation cohort was represented by the remaining
patients (n = 1127). At 6-month follow-up, 4.7% reached the
composite end point (Table 2). When patients of the validation
cohort were stratified, there is a progressive significant pattern
of increasing event rate as the Florence prediction rule
increased (P b .001). The validation cohort presented a
homogenous pattern with the test cohort as the slope of the
increase in event rates in comparison with the increase in the
score of the Florence prediction rule was not statistically
significant (slope of test cohort of 5.71 vs slope of validation
cohort of 6.05, P = .853) in the 2 cohorts (Fig. 2). The C
statistic for the model in the validation cohort was 0.81, not
significantly different from the test cohort (P = .649).Table 4 Sensitivity, specificity, and predictive values of patients enro
Patients with CP Patients enrolled in the study
Group A
Sensitivity 0.88
Specificity 0.63
Positive predictive value 0.11
Negative predictive value 0.99
Diagnostic accuracy 0.953.3. Exploring potential clinical impact of the
Florence prediction rule
To explore the potential impact of the present prediction
rule in the clinical practice, we first categorized patients
with low-risk CP into 3 risk group: group A, prediction
rule 0 or 1 (n = 1352, 61%); group B, prediction rule 2 to
4 (n = 670, 30%); and group C, prediction rule 5 or 6 (n =
211, 9.5%). Patients in group A showed a very low
incidence of composite end point (1%), whereas patients in
group C showed an unexpected very high incidence of the
end point (24.6%) in face of the initial recognition of
patients with low-risk CP (C vs A, P b .001). The
sensitivity, specificity, and predictive values are shown in
Table 4. As shown in Fig. 3, in our test cohort, we found a
progressive significant (P b .001) increase of the composite
end point of up to 24.6%, in both myocardial infarction
and revascularization. In particular, the rate of myocardial
infarction increased from almost 0% in group A to 4% in
group C, thus identifying 2 extreme risk groups. A similar
incidence rate for each of the end points was found in the
validation cohort.
3.4. The potential usefulness of the Florence
prediction rule
To investigate the potential usefulness of the prediction
rule for screening patients with CP in the CP unit, we
conducted a post hoc analysis restricted to the population
submitted to ETT (n = 798), by comparing the prognostic
yield of the prediction rule with that of ETT. First, we
stratified ETT patients according to the Florence predic-
tion rule (groups A, B, and C) and we compared the
event rate in each category with negative or positive ETT.
When we focused on group A (event rate, 3.6%; n = 7),
only 13 of the 193 patients tested showed a positive ETT
(6.7%) and only 4 (2.1%) of those reached the end point.
Moreover, in the same group, only 3 (1.7%) of 180
patients with negative ETT reached the end point, similar
to the pretest (3.6%). Thus, in this very low risk
subgroup ETT prognostic yield may be questionable.
Conversely, the patients of group C who had a negative
ETT experienced an event rate of up to 17.4%,
suggesting the need for higher sensitivity testing (stresslled in the study and submitted to ETT
(n=2233) Patients submitted to ETT (n = 798)
Group C Group A Group C
0.48 0.57 0.42
0.93 0.95 0.83
0.25 0.31 0.50
0.97 0.98 0.77
0.95 0.96 0.71
Fig. 3 Rate of coronary events including acute myocardial infarction, and revascularization in patients of the study (2233).
140 A. Conti et al.echocardiography, or stress nuclear imaging, or at least
coronary angiography).Fig. 4 Comparison of posttest likelihood with pretest likelihood
in patients submitted to ETT (n = 798).4. Discussion
This study showed a new simple clinical risk score, the
Florence prediction rule, was accurate in stratifying the
cardiovascular risk of patients with CP, without existing
known coronary disease, and initial negative work-up,
usually considered at low risk for future coronary events.
The clinical prediction rule, composed of 5 independent
prognostic variables (CP score higher than 6, male gender,
age older than 50 years, MS, and DM), identifies 3 groups of
patients with a risk ranging from 1% (group A, rule 0-1) to
25% (group C, rule 5-6) (Figs. 3 and 4).
The strengths of our study are as follows:
1) To our knowledge, this is the first prediction rule that is
easy to use and is applicable in clinical practice for risk
stratification of patients with CP and initial negative
work-up.
2) Patients with a prediction rule of 1 or less belonged
to a very low risk group (group A; event rate 1%)
which account for 60% of the population enrolled in
the study.
3) Patients with a prediction rule higher than 4 (group C)
were considered at very high risk, showing an eventrate of up to 25%, comparable with that of patients with
unstable angina and positive troponin test.
In the past years, several multivariate algorithms have
been developed in patients with CP for estimating the need
of intensive care [3,5-7,31,32]. However, those studies were
performed before troponin testing was routinely available,
thus including patients considered at high risk, per se, to
date. Thus, a prediction rule which stratifies patients
considered at low risk beyond first-line work-up is still
141A clinical prediction rule to manage acute chest pain patientslacking. According to classical definition, our population
should be considered as at low risk because they were
managed with observation, serial ECGs, troponins, and
echocardiography. Nonetheless, we recognized that these
patients were heterogeneous; in fact, they presented with
different clinical risk profiles, based on both clinical
presentation and the presence of cardiovascular risk factors,
and, finally, showed different outcomes. Previous risk
models well stratified the overall population of patients
with CP at hospital admission; however, they appeared
complex to be integrated in clinical practice [3,5-7,32,33].
We sought to investigate the relationship between the
presence of clinical variables that are easily detectable and
adverse cardiovascular outcome. We found that cardiovas-
cular risk factors (age N50 years, diabetes, male gender, and
metabolic syndrome) together with CP clinical character-
istics (CP score N6) were able to well stratify a large cohort of
patients with CP and negative initial work-up (Fig. 2).
Among the variables selected, the clinical characteristics of
CP at presentation took a remarkable weight in the
evaluation of patients with CP as the presence of CP score
higher than 6 in our derivation cohort has a factor of 3, which
was 3-fold higher than in the other variables, and identifies,
per se, patients at substantial risk of short-term adverse
coronary events (up to 6%).
The first risk group (group A) showed a very low
probability of future cardiac events. Of note, in this large
first group of patients, the 1% coronary event rate at follow-
up is even lower than the risk reported in the same “low-
risk” patients in a previous study [1,2]. Moreover, in the
same very low-risk group, the low cost and worldwide
availability of ETT did not substantially increase the ability
in ruling out future coronary events as compared with the
prediction rule (1.7% vs 3.6% event rate of the pretest).
Thus, these patients could be reasonably considered for safe
discharge without further investigation or managed on an
outpatient basis, thus economizing on stress testing. This
strategy could represent an attractive option for CP screen-
ing in the ED in a public health care delivery setting, because
patients in group A of our series account for at least 21%
(1352/6396) of the whole population with CP presenting to
the ED and 60% (1352/2233) of patients with CP and
normal ECG. On the other hand, the event rate in patients of
group C is substantially the same for patients with angina
and abnormal troponins, called “high-risk” patients in
previous studies [19] (Fig. 4). Moreover, the rate of
myocardial infarction in group C increased by up to 4%,
which was 2-fold higher than that usually identified for
patients with low-risk CP (b2%) [2,19]. These observations
could lead to a possible implication in decision making [34].
In fact, patients in group C with negative ETT retained a
high cardiovascular risk (17.4%) and should be considered
for admission or further evaluation to rule out the presence
of coronary disease before safe discharge. Patients with
intermediate risk (group B, score 2-4) appear to be the
population that could benefit from in-hospital ETT.4.1. Study limitations
Regarding the extensibility of the study to symptomatic
general population, one of the main limitations is the
exclusion of patients with prior diagnosis of coronary artery
disease, resting echocardiographic left ventricular dysfunc-
tion, or wall motion abnormalities. Moreover, the results
obtained in our series are relative to our large teaching
hospital and need validation in other centers.
Considering the potential impact of the prediction rule on
a more rational use of ETT in patients with CP, we conducted
a post hoc analysis on patients who underwent ETT. The
preliminary results of this analysis need to be confirmed in a
properly designed study. Finally, the evaluation of outcome
based on dichotomy (normal/abnormal tests) may be a
limitation of any screening work-up in patients with CP.5. Conclusions
The present simple clinical prediction rule accurately
predicts the risk of coronary events in patients with acute CP
and normal ECG, without existing known coronary disease,
and may be a valuable tool for guiding their management by
a threshold approach to clinical decision making [34].References
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